| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10,4 M € | +4.3% | 9,9 M € | +1.8% | 9,8 M € | +11.1% | 8,8 M € | +16.1% | 7,6 M € | -3.0% | 7,8 M € | +28.4% | 6,1 M € | +2.3% | 5,9 M € | +5.2% | 5,7 M € | -0.5% | 5,7 M € | +3.1% | 5,5 M € | +2.1% | 5,4 M € | +7.9% | 5,0 M € | -6.3% | 5,3 M € | +7.4% | 5,0 M € | -5.7% | 5,3 M € | +7.9% | 4,9 M € | -4.4% | 5,1 M € | +1.5% | 5,0 M € | |
| EBITDA | 443,0 k € | +51.5% | 292,5 k € | -58.2% | 699,8 k € | -25.9% | 943,9 k € | -26.0% | 1,3 M € | +165.9% | 480,0 k € | +220.3% | 149,9 k € | +45.6% | 102,9 k € | +321.8% | 24,4 k € | -97.1% | 855,6 k € | +31.8% | 648,9 k € | +284.8% | -351,2 k € | +53.3% | -752,3 k € | -1482.2% | -47,5 k € | -108.6% | 550,8 k € | -15.1% | 649,0 k € | -2.4% | 664,8 k € | +364.4% | 143,2 k € | -14.7% | 167,9 k € | |
| Operating profit | 262,0 k € | +36.3% | 192,2 k € | -68.6% | 611,9 k € | -25.8% | 824,7 k € | -28.3% | 1,2 M € | +231.3% | 347,4 k € | +1482.3% | 22,0 k € | +18.3% | 18,6 k € | +147.1% | -39,4 k € | -106.0% | 660,8 k € | +50.6% | 438,9 k € | +369.4% | -162,9 k € | +86.5% | -1,2 M € | -332.7% | -278,8 k € | -822.7% | 38,6 k € | -90.6% | 410,0 k € | -22.4% | 528,4 k € | +669.9% | 68,6 k € | -31.8% | 100,7 k € | |
| Profit/loss | 432,3 k € | +49.2% | 289,6 k € | -63.3% | 788,8 k € | +43.8% | 548,6 k € | -52.4% | 1,2 M € | +202.0% | 381,5 k € | +1577.5% | 22,7 k € | +90.8% | 11,9 k € | +127.2% | -43,7 k € | -106.7% | 657,2 k € | +53.5% | 428,2 k € | +278.5% | -239,8 k € | +86.1% | -1,7 M € | -305.1% | -426,0 k € | -1658.0% | 27,3 k € | -93.6% | 428,9 k € | -29.4% | 607,1 k € | +187.6% | 211,1 k € | +6.3% | 198,6 k € | |
| Equity | 6,7 M € | +6.9% | 6,3 M € | +4.8% | 6,0 M € | +15.1% | 5,2 M € | +11.8% | 4,7 M € | +32.8% | 3,5 M € | +12.2% | 3,1 M € | +0.7% | 3,1 M € | +0.4% | 3,1 M € | -1.4% | 3,1 M € | +26.5% | 2,5 M € | +20.9% | 2,1 M € | -10.5% | 2,3 M € | -42.9% | 4,0 M € | -9.6% | 4,4 M € | +0.6% | 4,4 M € | +10.8% | 4,0 M € | +18.0% | 3,4 M € | +6.7% | 3,2 M € | |
| Total assets | 9,3 M € | +8.9% | 8,5 M € | +5.8% | 8,0 M € | +21.9% | 6,6 M € | +21.9% | 5,4 M € | +19.6% | 4,5 M € | +0.8% | 4,5 M € | +12.8% | 4,0 M € | +3.6% | 3,8 M € | +2.5% | 3,7 M € | +6.9% | 3,5 M € | +21.3% | 2,9 M € | -7.7% | 3,1 M € | -39.3% | 5,2 M € | -6.7% | 5,5 M € | -8.5% | 6,0 M € | +8.6% | 5,6 M € | +6.1% | 5,2 M € | -2.4% | 5,4 M € | |
| Cash | 4,8 M € | +38.0% | 3,5 M € | -14.6% | 4,1 M € | +25.3% | 3,2 M € | +25.3% | 2,6 M € | -6.1% | 2,8 M € | -1.3% | 2,8 M € | +12.5% | 2,5 M € | +22.6% | 2,0 M € | -12.6% | 2,3 M € | +7.3% | 2,2 M € | +36.4% | 1,6 M € | +285.6% | 411,0 k € | -35.1% | 633,3 k € | -70.8% | 2,2 M € | +8.7% | 2,0 M € | -17.6% | 2,4 M € | -14.3% | 2,8 M € | +56.2% | 1,8 M € | |
| Debts | 1,7 M € | +1.2% | 1,7 M € | +8.2% | 1,6 M € | +22.0% | 1,3 M € | +81.5% | 718,0 k € | -25.2% | 959,9 k € | +29.0% | 744,1 k € | -12.0% | 845,9 k € | +17.8% | 718,0 k € | +32.5% | 541,9 k € | +15.6% | 468,8 k € | -6.4% | 500,7 k € | -32.3% | 739,9 k € | -32.9% | 1,1 M € | +7.7% | 1,0 M € | -13.7% | 1,2 M € | +44.5% | 822,5 k € | -19.1% | 1,0 M € | -24.5% | 1,3 M € | |
| Staff | 28,6 | 26,3 | 24,9 | 24,4 | 25,7 | 25,4 | 24,7 | 24,2 | 24,7 | 24,3 | 24,7 | 23,3 | 23,5 | 22,8 | 22,1 | 19 | 22,9 | 23 | 22,8 | |||||||||||||||||||
Non-profit organization · Bruxelles · incorporated on 26/10/1966 · 28,6 ETP
Non-profit organization profitable and well capitalised. Cash position rising (+38.0%).
Solid counterparty for a standard engagement.
ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE is a Non-profit organization incorporated in 1966. Its main activity is: Other professional, scientific and technical activities. Its registered office is in Bruxelles. It employs on average 28,6 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette